• Trending
  • Latest
    Sign in Sign up
    • Log In
    • Register
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Mashup Score: 0
      Cagent Initiates POINT FORCE Registry of Serranator PTA Catheter - Endovascular Today - 5 month(s) ago

      January 28, 2025—Cagent Vascular, Inc., a developer of serration technology for vessel dilation in endovascular interventions, announced the sta

      Source: evtoday.com
      Categories: General Medicine News, Cardiologists
      Tweet Tweets with this article
      • Profile photo of 	EVToday
        EVToday

        Cagent Initiates POINT FORCE Registry of Serranator PTA Catheter | @CagentVascular https://t.co/IhBu4bFMrE

    • Mashup Score: 3
      Bentley’s BeFlow Covered Stent for Iliac Occlusive Diseases Launched in Europe - Endovascular Today - 5 month(s) ago

      January 28, 2025—Bentley InnoMed GmbH announced the market launch of its BeFlow iliac covered stent system, which will be commercially available

      Source: evtoday.com
      Categories: General Medicine News, Cardiologists
      Tweet Tweets with this article
      • Profile photo of 	EVToday
        EVToday

        Bentley’s BeFlow Covered Stent for Iliac Occlusive Diseases Launched in Europe https://t.co/xgatUauxpA

    • Mashup Score: 4
      Instylla’s Tembo Embolic System Receives FDA Clearance - Endovascular Today - 5 month(s) ago

      January 28, 2025—Instylla, Inc., a developer of solutions for peripheral vascular embolotherapy, announced the FDA 510(k) clearance of the Tembo

      Source: evtoday.com
      Categories: General Medicine News, Cardiologists
      Tweet Tweets with this article
      • Profile photo of 	EVToday
        EVToday

        Instylla’s Tembo Embolic System Receives FDA Clearance | @instylla https://t.co/kuuh3NmtjU

    • Mashup Score: 2
      Artivion AMDS Evaluated in PERSEVERE Trial - Endovascular Today - 5 month(s) ago

      January 27, 2025—Artivion, Inc. announced the presentation of clinical data from the PERSEVERE United States investigational device exemption (I

      Source: evtoday.com
      Categories: General Medicine News, Cardiologists
      Tweet Tweets with this article
      • Profile photo of 	EVToday
        EVToday

        Artivion AMDS Evaluated in PERSEVERE Trial | @ArtivionInc https://t.co/6GQ7XFcWDp

    • Mashup Score: 14
      Setting the New Standard for Arterial Thrombectomy - Endovascular Today - 5 month(s) ago

      Introducing Artix, a dual aspiration and mechanical thrombectomy solution designed to address a broad spectrum of arterial thrombus cases.

      Source: evtoday.com
      Categories: General Medicine News, Cardiologists
      Tweet Tweets with this article
      • Profile photo of 	EVToday
        EVToday

        Explore four compelling cases that showcase the Artix Thrombectomy System in the treatment of peripheral arterial thromboembolism. Click to read the full article and see how Artix is redefining arterial thrombectomy. | #Sponsored by @InariMedical https://t.co/yUTasjeQh8

    • Mashup Score: 3
      Imperative Care’s Zoom System Receives FDA Clearance - Endovascular Today - 5 month(s) ago

      January 27, 2025—Imperative Care, Inc. announced that it has received FDA 510(k) clearance of the company’s Zoom system. The comprehensive

      Source: evtoday.com
      Categories: General Medicine News, Cardiologists
      Tweet Tweets with this article
      • Profile photo of 	EVToday
        EVToday

        Imperative Care’s Zoom System Receives FDA Clearance | @Imperative_Care https://t.co/P46kycURTn

    • Mashup Score: 9
      Adopting New DVT Tools: What Are the Key Questions to Ask Beforehand? - Endovascular Today - 5 month(s) ago

      An assessment of essential considerations for clinicians adopting new DVT tools, focusing on efficacy, safety, and integration into existing protocols to ensure effective and safe adoption.

      Source: evtoday.com
      Categories: General Medicine News, Cardiologists
      Tweet Tweets with this article
      • Profile photo of 	EVToday
        EVToday

        Pedram Keshavarz, MD; Jonas Kruse, MD; John M. Moriarty, MD; and Mona Ranade, MD, talk through the essential considerations for clinicians adopting new DVT tools, focusing on efficacy, safety, and integration into existing protocols. https://t.co/YTlrPxXqTN

    • Mashup Score: 2
      Exploring the Potential for a “Response Team” Concept in Deep Vein Thrombosis - Endovascular Today - 5 month(s) ago

      Dr. Suresh Vedantham asks Drs. Pavan Kavali and Kristen Sanfilippo about possible benefits of a DVT response team model, barriers to adoption, patient selection and medical management considerations, and implications for clinical research.

      Source: evtoday.com
      Categories: General Medicine News, Cardiologists
      Tweet Tweets with this article
      • Profile photo of 	EVToday
        EVToday

        Dr. Suresh Vedantham moderates Drs. Pavan Kavali & Kristen Sanfilippo in a discussion on the deep venous thrombosis response team concept, including possible benefits & barriers, patient selection & medical management considerations, & more. https://t.co/UcFWW2l43x

    • Mashup Score: 1
      Front Line’s COBRA-OS for REBOA Procedures Launched in United Kingdom - Endovascular Today - 5 month(s) ago

      January 23, 2025—Front Line Medical Technologies announced the launch in the United Kingdom of its CE Mark-approved COBRA-OS—Control of Bl

      Source: evtoday.com
      Categories: General Medicine News, Cardiologists
      Tweet Tweets with this article
      • Profile photo of 	EVToday
        EVToday

        Front Line’s COBRA-OS for REBOA Procedures Launched in United Kingdom | @frontlinecobra https://t.co/9iog132yKI

    • Mashup Score: 1
      Beyond Chronicity: Clot Characteristics and How They Drive Decisions in Deep Venous Disease - Endovascular Today - 5 month(s) ago

      The knowns and unknowns about venous thrombus biology as it relates to in-stent restenosis and how these results drive patient care.

      Source: evtoday.com
      Categories: General Medicine News, Cardiologists
      Tweet Tweets with this article
      • Profile photo of 	EVToday
        EVToday

        Drs. Minhaj S. Khaja (@VIRkhaja), Oscar Moreno (@OscarMorenoMD), and Andrea Tara Obi (@AndreaObiMD) review the knowns and unknowns about venous thrombus biology as it relates to in-stent restenosis and how these results drive patient care. https://t.co/XAuvceZHBc

    Load More
    ASCO 2025

    Advertisement

    Advertisement

    MashupMD
    © 2025 - Mashup Media LLC
    • Terms of Use
    • Privacy Policy
    • Cookie Settings